Related Experiment Video
Updated: Aug 17, 2026

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Clinical-diffusion mismatch predicts the putative penumbra with high specificity
Jane Prosser1, Ken Butcher, Louise Allport
1Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
Background And Purpose:
Perfusion-diffusion (PWI-DWI) mismatch may represent the ischemic penumbra. The complexities associated with perfusion-weighted imaging (PWI) have restricted its use. Mismatch between stroke severity, assessed with the National Institutes of Health Stroke Scale (NIHSS), and the volume of the diffusion-weighted imaging (DWI) lesion (clinical-diffusion mismatch; CDM) has been suggested as a surrogate for PWI-DWI mismatch. We compared CDM with PWI and DWI in acute stroke.
Methods:
Seventy-nine hemispheric stroke patients were imaged within 24 hours of symptom onset and subacutely (3 to 5 days). CDM was defined as NIHSS > or =8 and DWI < or =25 mL. DWI lesion and PWI (Tmax+4s) volumes were measured by planimetric techniques. Acute PWI-DWI mismatch was examined as a continuous variable (mismatch volume=PWIvol-DWIvol) and a categorical variable (mismatch=PWIvol-DWIvol/DWIvol x 100>20%). Early infarct expansion was calculated as DWI(subacute vol/DWI(acute vol).
Results:
In the 54 sub-6-hour patients, CDM detected PWI-DWI mismatch with a specificity of 93% (95% confidence interval [CI], 62% to 99%), a positive predictive value of 95% (95% CI, 77% to 100%), but a sensitivity of only 53% (95% CI, 34% to 68%). Alternate DWI and NIHSS cutpoints did not improve test performance characteristics. In addition, subacute DWI expansion was significantly greater in patients with CDM (P=0.01) compared with those without.
Conclusions:
CDM (NIH > or =8, DWI < or =25 mL) predicts the presence of PWI-DWI mismatch with high specificity and low sensitivity. CDM also predicts DWI expansion. CDM may be a useful selection tool in acute stroke therapies, including thrombolysis.
Insights
Clinical-diffusion mismatch (CDM) identifies perfusion-diffusion (PWI-DWI) mismatch in acute stroke patients with high specificity. This finding suggests CDM may aid in selecting patients for therapies like thrombolysis.
Area of Science:
- Neurology
- Radiology
- Stroke Imaging
Background:
- Perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI) are crucial for identifying the ischemic penumbra in acute stroke.
- Complexities of PWI have limited its clinical application.
- Clinical-diffusion mismatch (CDM) using the National Institutes of Health Stroke Scale (NIHSS) and DWI lesion volume is proposed as a surrogate for PWI-DWI mismatch.
Purpose of the Study:
- To compare the diagnostic performance of CDM against PWI-DWI mismatch in acute stroke patients.
- To evaluate CDM as a potential surrogate marker for PWI-DWI mismatch.
- To assess the predictive value of CDM for early infarct expansion.
Main Methods:
- Seventy-nine acute hemispheric stroke patients underwent imaging within 24 hours and subacutely.
- CDM was defined as NIHSS ≥8 and DWI lesion volume ≤25 mL.
- PWI-DWI mismatch and early infarct expansion were quantified using planimetric techniques.
Main Results:
- In patients treated within 6 hours, CDM demonstrated high specificity (93%) and positive predictive value (95%) for PWI-DWI mismatch, but low sensitivity (53%).
- Altering NIHSS or DWI cutpoints did not enhance CDM's performance.
- Subacute DWI lesion expansion was significantly greater in patients with CDM.
Conclusions:
- CDM (NIHSS ≥8, DWI ≤25 mL) effectively predicts PWI-DWI mismatch with high specificity, albeit with low sensitivity.
- CDM is also predictive of DWI lesion expansion.
- CDM may serve as a valuable tool for selecting acute stroke patients for reperfusion therapies, including thrombolysis.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Protein Diffusion in the Membrane
